Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis. (18th November 2020)
- Record Type:
- Journal Article
- Title:
- Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis. (18th November 2020)
- Main Title:
- Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
- Authors:
- Keown, Karen
Reid, Alastair
Moore, John E.
Taggart, Clifford C.
Downey, Damian G. - Abstract:
- Objectives: Cystic fibrosis (CF) lung disease is characterised by mucus stasis, chronic infection and inflammation, causing progressive structural lung disease and eventual respiratory failure. CF airways are inhabited by an ecologically diverse polymicrobial environment with vast potential for interspecies interactions, which may be a contributing factor to disease progression. Pseudomonas aeruginosa and Aspergillus fumigatus are the most common bacterial and fungal species present in CF airways respectively and coinfection results in a worse disease phenotype. Methods: In this review we examine existing expert knowledge of chronic co-infection with P. aeruginosa and A. fumigatus in CF patients. We summarise the mechanisms of interaction and evaluate the clinical and inflammatory impacts of this co-infection. Results: P. aeruginosa inhibits A. fumigatus through multiple mechanisms: phenazine secretion, iron competition, quorum sensing and through diffusible small molecules. A. fumigatus reciprocates inhibition through gliotoxin release and phenotypic adaptations enabling evasion of P. aeruginosa inhibition. Volatile organic compounds secreted by P. aeruginosa stimulate A. fumigatus growth, while A. fumigatus stimulates P. aeruginosa production of cytotoxic elastase. Conclusion: A complex bi-directional relationship exists between P. aeruginosa and A. fumigatus, exhibiting both mutually antagonistic and cooperative facets. Cross-sectional data indicate a worsened diseaseObjectives: Cystic fibrosis (CF) lung disease is characterised by mucus stasis, chronic infection and inflammation, causing progressive structural lung disease and eventual respiratory failure. CF airways are inhabited by an ecologically diverse polymicrobial environment with vast potential for interspecies interactions, which may be a contributing factor to disease progression. Pseudomonas aeruginosa and Aspergillus fumigatus are the most common bacterial and fungal species present in CF airways respectively and coinfection results in a worse disease phenotype. Methods: In this review we examine existing expert knowledge of chronic co-infection with P. aeruginosa and A. fumigatus in CF patients. We summarise the mechanisms of interaction and evaluate the clinical and inflammatory impacts of this co-infection. Results: P. aeruginosa inhibits A. fumigatus through multiple mechanisms: phenazine secretion, iron competition, quorum sensing and through diffusible small molecules. A. fumigatus reciprocates inhibition through gliotoxin release and phenotypic adaptations enabling evasion of P. aeruginosa inhibition. Volatile organic compounds secreted by P. aeruginosa stimulate A. fumigatus growth, while A. fumigatus stimulates P. aeruginosa production of cytotoxic elastase. Conclusion: A complex bi-directional relationship exists between P. aeruginosa and A. fumigatus, exhibiting both mutually antagonistic and cooperative facets. Cross-sectional data indicate a worsened disease state in coinfected patients; however, robust longitudinal studies are required to derive causality and to determine whether interspecies interaction contributes to disease progression. A complex relationship exists between P. aeruginosa and A. fumigatus and is associated with worsened clinical disease in cystic fibrosis. Further study of organism interactions, longitudinal outcomes and therapeutic strategies is warranted. https://bit.ly/2A161bh … (more)
- Is Part Of:
- European respiratory review. Volume 29:Number 158(2020)
- Journal:
- European respiratory review
- Issue:
- Volume 29:Number 158(2020)
- Issue Display:
- Volume 29, Issue 158 (2020)
- Year:
- 2020
- Volume:
- 29
- Issue:
- 158
- Issue Sort Value:
- 2020-0029-0158-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-11-18
- Subjects:
- Respiratory organs -- Diseases -- Periodicals
Respiratory Tract Diseases
Respiratory organs -- Diseases
Respiratory organs -- Diseases -- Treatment
Electronic journals
Periodical
Periodicals
Periodicals
616.2 - Journal URLs:
- https://err.ersjournals.com/content/by/year ↗
http://www.maney.co.uk/search?fwaction=show&fwid=381 ↗
http://www.ersnet.org/ ↗ - DOI:
- 10.1183/16000617.0011-2020 ↗
- Languages:
- English
- ISSNs:
- 0905-9180
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24785.xml